Fly-E Group, Inc. (NASDAQ: FLYE) has 300 million shares of common stock authorized against just 1,632,386 outstanding — a ratio of roughly 184 to 1. That gap of 298.4 million unissued shares requires no shareholder vote or charter amendment to deploy. The board can issue into it at will, constrained only by Nasdaq's 20% rule, which caps a single non-shareholder-approved placement at roughly 326,000 shares.
The company's public float — the portion of shares available for open-market trading — stands at approximately 1,555,386, or about 95% of outstanding. That number is derived by subtracting a 77,000-share block held by CEO Zhou Ou, the only disclosed insider holder.
What makes the structure unusual is how it got this small.
Two Splits, One Pattern
In July 2025, FLYE executed a 1-for-5 reverse split. Four months later, it executed a 1-for-20. Together those two splits compressed 24,587,500 pre-split shares into today's 1,632,386 — a cumulative 100-to-1 reduction. Shareholders then approved a third reverse split on June 17, 2026, at a board-discretionary ratio of 1-for-5 up to 1-for-100, exercisable at any time through June 2027. At the maximum ratio the float would shrink to roughly 15,554 shares.
The historical pattern matters: the November 2025 split came five weeks after a $16.00-per-share private placement — a PIPE, or private investment in public equity — that sold 687,500 shares to unnamed individual investors. That single block represents 42.1% of all shares outstanding today.
Current Dilution Machinery: Almost None
Today the structure is mechanically clean. There are no convertible notes, no preferred stock outstanding, no at-the-market offering facility — an ATM, meaning a program that drips new shares into the open market continuously — no standby equity purchase agreement, and no effective shelf registration — a pre-filed SEC document that lets a company issue securities on short notice.
The only live warrants — contracts giving a holder the right to buy shares at a set price — are 1,294 shares held by IPO underwriter Benchmark Company at a $400 strike. Those warrants sit roughly 231 times above the prevailing market and represent 0.08% of the float. They are economically inert.
Three independent data sources — XBRL filings, the 10-K cover page, and market-data feeds — agree on the same share count across three consecutive reporting dates spanning eight months. Zero new shares have been issued since December 2025.
Where the Risk Actually Sits
The dilution risk score is 4 out of 10 — moderate. The score is held down by the absence of any active dilution mechanism: no toxic convertibles, no floating-discount notes, no reset warrants. It is pushed up by the company's demonstrated financing cadence — roughly one capital event every eight to ten weeks across the prior 24 months — and by a cash position of approximately $300,000 against $3.9 million in defaulted bank debt and an estimated $3.5 million quarterly operating cash burn.
That cash runway is measured in weeks, not quarters. Without a new raise, the company would need to find alternative financing or restructure existing obligations. Any fresh equity issuance would be visible in advance — there is no shelf or ATM in place, so FLYE would have to file a new S-1 registration statement or execute a private placement, both of which create a public paper trail.
An unresolved data conflict adds a secondary wrinkle: the July 2026 annual report claims insiders hold 18.7% of outstanding shares, while the May 2026 proxy puts the figure at 4.7%. If the higher number is correct, the true tradeable float is closer to 1,327,000 — roughly 15% tighter than published figures indicate — and no Form 4 insider-transaction filings have surfaced to explain the gap.